Recall Register

Diasorin Inc.: FDA recalls

Newest recall start date in this list: . DiaSorin LIAISON Q.S.E.T. Device Plus, REF 319060; intended for use in the preparation of human stool specimens

FDA enforcement events from 2015 to 2024; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Diasorin Inc. as the recalling firm in 6 events. The events have 6 product records. The recalls started from 2015 to 2024. All the events are device recalls. By FDA enforcement events, Diasorin Inc. is number 591 of 1,629 firms that have a page. Events that Diasorin Inc. started: 1 in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025. Class II is 100.0% of its events and 73.7% of all FDA events.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

6 events, newest first.

FDA enforcement events of Diasorin Inc.
InitiatedProduct (first record)TypeClassRecordsStatus
7 Nov 2024DiaSorin LIAISON Q.S.E.T. Device Plus, REF 319060; intended for use in the preparation of human stool specimensDeviceClass II1Ongoing
13 Dec 2023DiaSorin LIAISON HSV-2 Type Specific IgG, REF 310620DeviceClass II1Ongoing
23 Nov 2020LIAISON 1-84 PTH Assay - Product Usage: is an in vitro chemiluminescent immunoassay (CLIA) intended for the quantitative determination of parathyroid hormone (1-84) in human serum and EDTA plasma. Measurements of parathyroid hormone levels are used in the differential diagnosis of hypercalcemia and hypocalcemia…DeviceClass II1Terminated
17 Jul 2020Parvovirus B19 IgG EIA kit Part No. V519IGUSDeviceClass II1Ongoing
13 Jul 2016LIAISON Estradiol II Gen, 310680, 310680-CN The DiaSorin LIAISON Estradiol II Gen assay is a chemiluminescent immunoassay (CLIA) intended for the quantitative determination of estradiol in human serum. Assay results should be used in conjunction with other clinical and laboratory data to assist in the diagnosis and…DeviceClass II1Terminated
16 Mar 2015DiaSorin, PRO-Trac II Tacrolimus ELISA kit, REF 32400 and 32400-CN. Product Usage: The PRO-Trac II Tacrolimus ELISA kit is an in vitro reagent system intended for the quantitative determination of tacrolimus (Prografl, FK506) and some metabolites in human EDT A or heparinized whole blood as an aid in the management…DeviceClass II1Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

Diasorin Inc.: events for each product type
TypeEvents
Device6
Diasorin Inc.: events in each class
ClassEvents
Class II6
Share of the events of the firm in Class I
0%
Share of all events on the register in Class I
18%
Events with the status Ongoing
3

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Diasorin Inc., by the year that the recall started. The largest year is 2020, with 2 events.

Official channels

Cite this page

Recall Register. Diasorin Inc.: FDA recalls. https://recallregister.com/firm/diasorin-inc/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
MN

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Diasorin Inc. have?
Class II: 6 events. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of Diasorin Inc.?
FDA event 95829, which the firm started on 7 Nov 2024. The first product in the record is: DiaSorin LIAISON Q.S.E.T. Device Plus, REF 319060; intended for use in the preparation of human stool specimens
How many FDA recalls of Diasorin Inc. have the status Ongoing?
3 events have the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.